Renal Safety Profile of Di-Peptidyl-Peptidase Inhibitors: A Review of Available Literature

International Journal of Basic & Clinical Pharmacology

doi 10.18203/2319-2003.ijbcp20170544

Full Text

Abstract

Available in

Date

Authors

Publisher

Medip Academy

Related search

Pdb15 - Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors: Systematic Literature Review and Indirect Comparisons

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Exploration of Orally Available Calpain Inhibitors 2: Peptidyl Hemiacetal Derivatives

English

Clinical Efficacy and Safety Profile of Lofexidine Hydrochloride in Treating Opioid Withdrawal Symptoms: A Review of Literature

Cureus
2019English

Erratum To: Di-Peptidyl Peptidase-4 Inhibitor Sitagliptin Protects Vascular Function in Metabolic Syndrome: Possible Role of Epigenetic Regulation

Molecular Biology Reports
MedicineGeneticsMolecular Biology
2014English

Sphingosine Kinase Inhibitors: A Review of Patent Literature (2006-2015)

Expert Opinion on Therapeutic Patents
MedicineDrug DiscoveryPharmacology
2016English

Systematic Literature Review of DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus and Renal Impairment

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Pediatric Characteristics of 2019 Novel Coronavirus: Review of Available Published Literature

Clinical Pediatrics
Child HealthPediatricsPerinatology
2020English

Heterologous Expression of Peptidyl-Lys Metallopeptidase ofArmillaria Melleaand Mutagenic Analysis of the Recombinant Peptidase

Journal of Biochemistry
MedicineBiochemistryMolecular Biology
2015English

Safety Signal Detection: The Relevance of Literature Review

Drug Safety
ToxicologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy